{"id":14673,"date":"2015-11-11T10:04:17","date_gmt":"2015-11-11T09:04:17","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=14673"},"modified":"2021-10-08T11:01:02","modified_gmt":"2021-10-08T09:01:02","slug":"carrascosa-jm-vanaclocha-f-caloto-t-echave-m-oyaguez-i-tencer-t","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/carrascosa-jm-vanaclocha-f-caloto-t-echave-m-oyaguez-i-tencer-t\/","title":{"rendered":"Carrascosa JM, Vanaclocha F, Caloto T, Echave M, Oyag\u00fcez I, Tencer T"},"content":{"rendered":"<div class=\"col80\">\n<p class=\"miniatura_foto\" style=\"text-align: justify;\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-14157 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/09\/ISPOR.jpg\" alt=\"\" width=\"120\" height=\"120\" \/> Carrascosa JM, Vanaclocha F, Caloto T, Echave M, Oyag\u00fcez I, Tencer T<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<div class=\"col80p\">\n<h6 style=\"text-align: justify;\">Cost-utility analysis of apremilast for the treatment of moderate to severe psoriasis in Spain<\/h6>\n<h6 style=\"text-align: justify;\"><strong>18th Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015<\/strong><\/h6>\n<p><a href=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/10\/163.pdf\" target=\"_blank\" rel=\"noopener\">POSTER<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Carrascosa JM, Vanaclocha F, Caloto T, Echave M, Oyag\u00fcez I, Tencer T &nbsp; &nbsp; Cost-utility analysis of apremilast for the treatment of moderate to severe psoriasis in Spain 18th Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015 POSTER<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[116,919,246],"tags":[],"class_list":["post-14673","post","type-post","status-publish","format-quote","hentry","category-ace-acu-tipo-de-proyecto","category-enfermedades-autoinmunes","category-international-society-of-pharmacoeconomics-and-outcomes-research","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14673"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=14673"}],"version-history":[{"count":1,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14673\/revisions"}],"predecessor-version":[{"id":14675,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14673\/revisions\/14675"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=14673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=14673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=14673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}